2430-01-5 Usage
Description
2-bromo-N,N-diethyl-acetamide is a chemical compound characterized by its molecular formula C6H12BrNO and a molar mass of 202.07 g/mol. It is a colorless to pale yellow liquid with a pungent odor, known for its role as an intermediate in the synthesis of pharmaceuticals and agrochemicals. As a brominated derivative of N,N-diethylacetamide, it also serves as a reagent in organic synthesis and a building block for the preparation of various functionalized compounds. Due to its corrosive nature and potential to irritate the eyes, skin, and respiratory system, it is crucial to handle this chemical with appropriate safety measures, including the use of gloves, goggles, and a fume hood.
Uses
Used in Pharmaceutical Synthesis:
2-bromo-N,N-diethyl-acetamide is utilized as an intermediate in the production of pharmaceuticals, contributing to the development of new medications and therapeutic agents. Its unique chemical properties allow for its integration into complex molecular structures, enhancing the efficacy and functionality of resulting pharmaceutical compounds.
Used in Agrochemical Production:
In the agrochemical industry, 2-bromo-N,N-diethyl-acetamide serves as a key intermediate, aiding in the synthesis of various agrochemicals designed to protect crops and enhance agricultural productivity. Its role in this sector underscores its versatility and importance in creating effective solutions for pest control and crop management.
Used as a Reagent in Organic Synthesis:
2-bromo-N,N-diethyl-acetamide is employed as a reagent in organic synthesis, facilitating the formation of new chemical bonds and the creation of novel organic compounds. Its reactivity and stability make it a valuable tool in the synthesis of a wide range of organic molecules.
Used in the Preparation of Functionalized Compounds:
As a building block, 2-bromo-N,N-diethyl-acetamide is instrumental in the preparation of various functionalized compounds. Its ability to be incorporated into different chemical frameworks allows for the development of specialized materials with tailored properties for specific applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 2430-01-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,3 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2430-01:
(6*2)+(5*4)+(4*3)+(3*0)+(2*0)+(1*1)=45
45 % 10 = 5
So 2430-01-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H12BrNO/c1-3-8(4-2)6(9)5-7/h3-5H2,1-2H3
2430-01-5Relevant articles and documents
A new facile synthesis of a thromboxane B2 precursor
Booysen,Holzapfel
, p. 1461 - 1472 (1995)
A short, stereocontrolled synthesis of a key intermediate in the synthesis of thromboxane B2 is described. The approach is based on the use of N,N-diethyl(phenylsulfonyl)acetamide as nucleophile in a palladium-catalysed nucleophilic substitutio
Facile peripheral modification of N-confused porphyrin
Qu, Wenchao,Ding, Tang,Cetin, Anil,Harvey, John D.,Taschner, Michael J.,Ziegler, Christopher J.
, p. 811 - 814 (2006)
An improved methodology for the N-alkylation of the porphyrin isomer N-confused porphyrin is presented. The combination of polar solvent conditions and the use of the base Cs2CO3 affords externally modified products in high yield wit
Quaternary ammonium salt type honokiol/magnolol derivative as well as preparation method and application thereof
-
Paragraph 0039; 0050-0051, (2021/06/26)
The invention discloses a series of novel quaternary ammonium salt honokiol/magnolol derivatives as well as a preparation method and application thereof. According to the series of compounds, honokiol/magnolol is taken as a raw material, a series of novel quaternary ammonium salt honokiol/magnolol derivatives are prepared on phenolic hydroxyl groups of honokiol/magnolol through a coupling reaction, and the structural general formula is shown in the specification. The compound disclosed by the invention has very strong antibacterial activity on staphylococcus aureus ATCC 29213 and clinically separated methicillin-resistant staphylococcus aureus (MRSA), most of the derivatives are higher than parent honokiol/magnolol, and the activity of part of the target derivatives is higher than that of a contrast drug levofloxacin. The compound is expected to be used for preparing drugs for resisting staphylococcus aureus and methicillin-resistant staphylococcus aureus.
Design, Synthesis, Antimicrobial Evaluation, and Laccase Catalysis Effect of Novel Benzofuran–Oxadiazole and Benzofuran–Triazole Hybrids
Faiz, Sadia,Zahoor, Ameer Fawad,Ajmal, Muhammad,Kamal, Shagufta,Ahmad, Sajjad,Abdelgawad, Abdelrahman M.,Elnaggar, Mehrez E.
, p. 2839 - 2852 (2019/11/03)
Novel structural hybrids of benzofuran–oxadiazole and benzofuran–triazole have been synthesized and evaluated for their potential against Staphylococcus aureus, Bacillus subtilis, and Escherichia coli. The excellent antibiotic activity was shown by compou
